NS
CRBP icon

NBC Securities’s Corbus Pharmaceuticals CRBP Stock Holding History

NBC Securities’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309 Hold
33
– – ﹤0.01% 2382
2026
Q1 		$309 Hold
33
– – ﹤0.01% 2492
2025
Q4 		$268 Hold
33
– – ﹤0.01% 2694
2025
Q3 		$417 Buy
+33
New +$314 ﹤0.01% 2662
2024
Q3 		– Sell
-33
Closed -$1K – 2132
2024
Q2 		$1K Hold
33
– – ﹤0.01% 2031
2024
Q1 		$1K Buy
+33
New +$814 ﹤0.01% 2053
2023
Q4 		– Sell
-33
Closed – – 2130
2023
Q3 		$0 Buy
+33
New +$228 ﹤0.01% 2121

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

NBC Securities's CRBP Position: Q2 2026 in Review

NBC Securities held its Corbus Pharmaceuticals (CRBP) position steady in Q2 2026 at 33 shares worth $309. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

NBC Securities first reported a position in CRBP in Q3 2023 and has held it in 7 quarters since. The position peaked at $1K in Q2 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • NBC Securities held 33 shares of Corbus Pharmaceuticals worth $309 as of Q2 2026.
  • NBC Securities left its Corbus Pharmaceuticals share count unchanged in Q2 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #2382 holding.
  • NBC Securities first reported a position in Corbus Pharmaceuticals in Q3 2023 and has held it in 7 quarters since.
  • NBC Securities's Corbus Pharmaceuticals position peaked at $1K in Q2 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.